v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows provided by (used in) operating activities:      
Net loss $ (192,354) $ (155,093)  
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 1,004 591  
Amortization of intangible assets 12,245 13,226  
Amortization of deferred contract costs 3,740 3,947  
Equity-based compensation 5,220 7,319  
Amortization of debt issuance costs 159 126  
Benefit from doubtful accounts receivable (208) (142)  
Loss on partial extinguishment of debt 0 507  
Non-cash restructuring charges 0 192  
Goodwill impairment charges 197,219 176,531 $ 196,064
Tax receivable agreement remeasurement (6,521) (20,664)  
Changes in fair value of contingent consideration (0) (690)  
Deferred income taxes (3,537) (11,007)  
Changes in operating assets and liabilities:      
Accounts receivable 13,259 10,351  
Prepaid expenses and other assets (4,022) (5,683)  
Deferred contract costs (2,868) (3,794)  
Accounts payable, accrued expenses and other liabilities (11,573) (8,745)  
Deferred revenue (199) 19,094  
Net cash provided by operating activities 11,564 26,066  
Cash flows (used in) provided by investing activities:      
Purchases of property, equipment, and data assets (3,202) (7,706)  
Purchases of short-term investments (12,500) (12,000)  
Maturities of short-term investments 9,481 103,251  
Net cash (used in) provided by investing activities (6,221) 83,545  
Cash flows (used in) provided by financing activities:      
Repayments of term loan (2,188) (246,250)  
Proceeds from term loan 0 175,000  
Payments of debt issuance costs 0 (1,660)  
Taxes paid related to net share settlement of equity awards (926) (1,874)  
Repurchases of Class A common stock 0 (21,155)  
Payments under Tax Receivable Agreement (7,762) (13,767)  
Net cash used in financing activities (10,876) (109,706)  
Net decrease in cash and cash equivalents (5,533) (95)  
Effect of exchange rate changes on cash and cash equivalents (446) 816  
Cash and cash equivalents, beginning of period 163,627 105,378 105,378
Cash and cash equivalents, end of period 157,648 106,099 $ 163,627
Supplemental cash flow disclosures:      
Interest 2,472 2,242  
Income taxes 93 32  
Supplemental disclosure of non-cash investing activities:      
Capital expenditures included in accounts payable and accrued expenses and other liabilities $ 3,758 $ 5,393